FWG Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.83M Sell
1,970
-22
-1% -$22.3K 0.69% 31
2025
Q4
$2.07M Sell
1,992
-33
-2% -$31.6K 0.78% 25
2025
Q3
$1.65M Buy
2,025
+47
+2% +$35K 0.71% 24
2025
Q2
$1.52M Buy
1,978
+31
+2% +$24.1K 0.72% 24
2025
Q1
$1.72M Sell
1,947
-76
-4% -$63.2K 0.85% 19
2024
Q4
$1.64M Buy
2,023
+12
+0.6% +$9.94K 0.79% 21
2024
Q3
$1.8M Sell
2,011
-407
-17% -$366K 0.89% 20
2024
Q2
$2.12M Buy
2,418
+106
+5% +$84.8K 1.07% 19
2024
Q1
$1.78M Buy
2,312
+51
+2% +$36.3K 0.96% 20
2023
Q4
$1.42M Sell
2,261
-43
-2% -$25.1K 0.84% 21
2023
Q3
$1.21M Sell
2,304
-77
-3% -$39.7K 0.81% 23
2023
Q2
$1.08M Sell
2,381
-23
-1% -$9.65K 0.68% 26
2023
Q1
$826K Sell
2,404
-261
-10% -$88K 0.6% 30
2022
Q4
$975K Buy
2,665
+328
+14% +$116K 0.68% 28
2022
Q3
$756K Buy
2,337
+420
+22% +$133K 0.57% 31
2022
Q2
$622K Buy
1,917
+1,075
+128% +$323K 0.54% 32
2022
Q1
$241K Hold
842
0.19% 79
2021
Q4
$205K Buy
+842
New +$213K 0.15% 92

Other funds holding LLY

FWG Holdings's LLY Position: Q1 2026 in Review

FWG Holdings reduced its Eli Lilly (LLY) stake by 1.1% in Q1 2026, selling an estimated $22.3K and leaving 1,970 shares worth $1.83M. The position accounts for 0.69% of the portfolio, ranked #31.

FWG Holdings first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.12M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • FWG Holdings held 1,970 shares of Eli Lilly worth $1.83M as of Q1 2026.
  • FWG Holdings sold 22 Eli Lilly shares in Q1 2026, an estimated $22.3K.
  • Eli Lilly made up 0.69% of FWG Holdings's portfolio in Q1 2026, its #31 holding.
  • FWG Holdings first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • FWG Holdings's Eli Lilly position peaked at $2.12M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on FWG Holdings's 13F filing for Q1 2026, filed 13 Apr 2026.